stockrow
Friday 6 November 2026
Export LFST’s income statement to Excel — free account
LifeStance Health Group, Inc.
LFST Healthcare Medical Care Facilities
LifeStance Health Group, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $1.4 billion, up 13.9% from fiscal 2024.
- Revenue
- +25.3%
- EPS
- +2,042.9%
- Free cash flow
- +31.6%
- Total debt
- −5.15%
Quarter to September 2026, against a year earlier
13.44
0.77
−5.42%
Follow LFST
Alert me
| Sep '26 From the 10-Q filed 5 Nov | Jun '26 | Mar '26 | Dec '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
63.25 | 80.53 | 101.11 | 283.87 |
+8 more quarters Free account |
P/S ratio |
2.73 | 2.59 | 1.65 | 1.91 | |
P/FCF ratio |
25.58 | 23.62 | 17.30 | 24.70 | |
P/Operating CF |
123.89 | 41.11 | 74.51 | 47.21 | |
P/B ratio |
3.07 | 2.78 | 1.67 | 1.79 | |
Price to Tangible BV |
270.39 | 0.00 | 467.56 | 54.35 | |
EV/Sales |
2.76 | 2.61 | 1.70 | 1.92 | |
EV/EBITDA |
28.70 | 30.90 | 25.30 | 34.22 | |
EV/Operating CF |
20.31 | 19.00 | 13.90 | 18.71 | |
EV/FCF |
25.79 | 23.81 | 17.77 | 24.86 | |
Quick Ratio |
1.30 | 1.23 | 1.33 | 1.37 | |
Current Ratio |
1.44 | 1.38 | 1.48 | 1.65 | |
Net Debt/EBITDA |
0.76 | 0.73 | 1.89 | 0.54 | |
Debt/Assets |
11.69% | 11.87% | 12.23% | 12.07% | |
Debt/Equity |
0.17 | 0.18 | 0.18 | 0.17 | |
Asset Turnover |
0.77 | 0.73 | 0.70 | 0.66 | |
Operating CF/Net income |
1.65 | 4.23 | 2.32 | 4.93 | |
Capex/Depreciation |
(0.96) | (0.83) | (0.79) | (0.80) | |
Interest Coverage |
13.28 | 11.65 | 12.43 | 6.29 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
24.87% | 24.84% | 24.87% | 24.80% | |
Intangible Assets out of Total Assets |
0.67 | 0.68 | 0.69 | 0.67 | |
Share Based Compensation of Revenue |
3.99% | 4.54% | 3.77% | 4.37% | |
Graham Net Nets |
(0.07) | (0.08) | (0.13) | (0.10) | |
Graham Number |
4.09 | 3.40 | 2.33 | 1.48 | |
Earnings Yield |
1.58% | 1.24% | 0.99% | 0.35% | |
Free Cash Flow Yield |
3.91% | 4.23% | 5.78% | 4.05% | |
Revenue per Share |
1.20 | 1.14 | 1.04 | 0.99 | |
Operating CF per Share |
0.10 | 0.26 | 0.09 | 0.15 | |
Capex per Share |
(0.04) | (0.03) | (0.03) | (0.03) | |
Free Cash Flow per Share |
0.06 | 0.23 | 0.06 | 0.12 | |
Cash per Share |
0.57 | 0.59 | 0.50 | 0.64 | |
Shareholders Equity per Share |
3.91 | 3.85 | 3.82 | 3.94 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
3.91 | 3.85 | 3.82 | 3.94 | |
Free Cash Flow |
22.36 | 87.92 | 22.34 | 46.65 | |
Working Capital |
115.65 | 103.21 | 116.18 | 164.24 | |
Capital Expenditures |
(14.65) | (11.99) | (10.77) | (10.91) | |
Net Current Asset Value |
(317.11) | (326.38) | (312.55) | (266.72) | |
EV/EBIT |
44.41 | 52.79 | 56.54 | 113.25 | |
Capex to Sales |
0.03 | 0.03 | 0.03 | 0.03 | |
Price to Operating Income |
44.05 | 52.37 | 55.03 | 112.54 | |
| Other line items | |||||
Average Receivables |
121.01 | 120.22 | 131.64 | 113.76 | |
Average Payables |
8.86 | 9.42 | 5.85 | 6.68 | |
Average Assets |
2,167.63 | 2,164.15 | 2,125.28 | 2,161.12 | |
Average Common Equity |
1,492.57 | 1,475.53 | 1,467.26 | 1,483.65 |
Columns are period end dates · fundamentals updated 5 Nov 2026